Status:
UNKNOWN
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
Lead Sponsor:
Assiut University
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
5-18 years
Brief Summary
. To determine pattern and frequency of dyslipoproteinemia in patients with newly diagnosed juvenile SLE and to assess effect of disease activity on lipid profile of patients with juvenile SLE.
Detailed Description
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem inflammation and the presence of circulating autoantibodies against self-antigens leading to inflammator...
Eligibility Criteria
Inclusion
- Patients who are diagnosed according to 2019 European League against Rheumatism (EULAR) /American College of Rheumatology (ACR) SLE classification criteria .
- Patients diagnosed with jSLE between 5 and 18 years of age
Exclusion
- 1\. Patients on lipid lowering drugs for any other reason. 2. Patients with other autoimmune disease.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06151990
Start Date
December 1 2023
End Date
October 1 2025
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt